[144] AMERISAFE, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for AMERISAFE, Inc. (AMSF) reports a proposed sale of 1,343 common shares, to be executed through Raymond James & Associates on or about 05 Aug 2025. The block is valued at approximately $66,099 and originates from RSU vesting on 01 Sep 2023; no cash consideration was paid at acquisition. The company lists 18,990,652 shares outstanding, making the transaction roughly 0.007 % of total shares.

No other insider sales were disclosed for the prior three-month period, and the filer certifies possession of no undisclosed material information. Given the modest size and routine nature of equity-compensation monetisation, the event is unlikely to exert meaningful pressure on AMSF’s share price, though investors often track such filings for sentiment cues.

Positive

• None.

Negative

• Insider intends to sell shares, which can be perceived as a mild negative signal, even though the amount is immaterial.

Insights

Equity Analyst

TL;DR – Minor Form 144 sale (0.007 % float) is routine; sentiment slightly negative but valuation impact negligible.

The filing signals an insider’s intent to dispose of 1,343 shares worth about $66 k. Relative to AMSF’s nearly 19 m share float, the sale is immaterial and should not affect liquidity or fundamentals. Absence of other recent sales and the RSU-vesting origin suggest normal diversification rather than bearish insider insight. Still, any insider sale can weigh modestly on market sentiment, particularly in thin-volume periods. Overall, I view the disclosure as neutral for valuation, with a marginally negative optics effect.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	1343	66099.00	18990652	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2023	RSU Vesting	Issuer			1343	09/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many AMSF shares are being sold under this Form 144?

1,343 common shares are proposed for sale.

What is the value of the AMSF shares listed in the filing?

The aggregate market value is estimated at $66,099.

When is the planned sale date for the AMSF Form 144 transaction?

The approximate sale date is 05 August 2025.

What percentage of AMERISAFE’s outstanding shares does the sale represent?

Roughly 0.007 % of the 18,990,652 shares outstanding.

Did the filer report any other AMSF share sales in the last three months?

No. The filing states "Nothing to Report" for prior three-month sales.

How were the shares being sold originally acquired?

They were obtained via RSU vesting on 01 Sep 2023 with no cash payment.